This content is Free Access.
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
39,035 Views
•
10:29 min
•
November 12, 2010
DOI:
Summary
Automatically generated
In this article, we examine the methodology and considerations relevant to the FDA approved depression treatment protocol using the Neuronetics NeuroStar TMS device.
Explore More Videos
NeuroStar TMS DeviceFDA Approved ProtocolTreatment Of DepressionNeuroStar Transcranial Magnetic Stimulation (TMS) SystemClass II Medical DevicePulsed Magnetic FieldsElectrical CurrentsCortexPhysiological ChangesFunctional Brain ChangesO’Reardon Et Al.Industry-sponsored Clinical TrialMajor DepressionAntidepressant Treatment TrialActive TMSSham TMSLeft Dorsolateral Prefrontal Cortex (DLPFC)Medication-free PatientsMontgomery-Asberg Depression Scale (MADRS)Hamilton Depression Rating Scale (HAMD)FDA Approval
Read Article
Cite this Article
Horvath, J. C., Mathews, J., Demitrack, M. A., Pascual-Leone, A. The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression. J. Vis. Exp. (45), e2345, doi:10.3791/2345 (2010).
Copy